200 related articles for article (PubMed ID: 10558537)
1. Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice.
Fed Regist; 1999 May; 64(92):25910-2. PubMed ID: 10558537
[TBL] [Abstract][Full Text] [Related]
2. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
[TBL] [Abstract][Full Text] [Related]
3. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
[TBL] [Abstract][Full Text] [Related]
4. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2001 Aug; 66(159):42944-6. PubMed ID: 11757558
[TBL] [Abstract][Full Text] [Related]
5. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
[TBL] [Abstract][Full Text] [Related]
6. Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(126):35920-31. PubMed ID: 17910137
[TBL] [Abstract][Full Text] [Related]
7. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
[TBL] [Abstract][Full Text] [Related]
8. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2006 Sep; 71(186):56008-27. PubMed ID: 17017470
[TBL] [Abstract][Full Text] [Related]
9. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
[TBL] [Abstract][Full Text] [Related]
10. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(144):43355-7. PubMed ID: 18949877
[TBL] [Abstract][Full Text] [Related]
11. Exemption of chemical mixtures. Final rule.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Mar; 72(47):10925-8. PubMed ID: 17450656
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
[TBL] [Abstract][Full Text] [Related]
13. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
[TBL] [Abstract][Full Text] [Related]
14. Control of immediate precursor used in the illicit manufacture of fentanyl as a schedule II controlled substance. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Jun; 75(124):37295-9. PubMed ID: 20608285
[TBL] [Abstract][Full Text] [Related]
15. Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2007 May; 72(85):24532-4. PubMed ID: 17520775
[TBL] [Abstract][Full Text] [Related]
16. The clandestine drug laboratory situation in the United States.
Frank RS
J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
[TBL] [Abstract][Full Text] [Related]
17. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Apr; 72(77):20039-47. PubMed ID: 17520757
[TBL] [Abstract][Full Text] [Related]
18. Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2005 Apr; 70(63):16935-7. PubMed ID: 15806735
[TBL] [Abstract][Full Text] [Related]
19. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
[TBL] [Abstract][Full Text] [Related]
20. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]